Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tria Health provides pharmacist-led chronic condition management services to improve health outcomes and reduce healthcare costs for employers and health plans. Their approach has demonstrated improved medication adherence, reduced A1C levels in diabetes patients (average reduction of 1.3), closure of care gaps (48% for diabetes), and average annual savings per engaged member ($2,432).
The company coordinates care between members, physicians, caregivers, and benefit solutions using data integration from multiple sources including remote monitoring devices.
They guarantee financial results with a risk-free model.
In partnership with RxBenefits, they launched the Optimize MyCare Diabetes Support Program to proactively manage diabetes through pharmacy claims review and targeted interventions.
Tria Health began as a pilot program focused on diabetes but expanded to cover broader chronic condition management for self-insured employers and health plans.
Key metrics include an overall ROI of 3.7 : 1 (with Rx savings alone at 1.6 : 1) and identification of an average of 1.7 medication-related problems per initial consultation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tria Health.